Advantageous toxicity profile of inhaled antisense oligonucleotides following chronic dosing in non-human primates-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advantageous toxicity profile of inhaled antisense oligonucleotides following chronic dosing in non-human primates

Published:2008-12 Issue:6 Volume:21 Page:845-854
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Guimond Alain,Viau Elisabeth,Aubé Paméla,Renzi Paolo M.,Paquet Luc,Ferrari Nicolay

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry (medical),Pulmonary and Respiratory Medicine

Reference54 articles.

1. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide;Zamecnik;Proc Natl Acad Sci USA,1978

2. Toxicology of antisense therapeutics;Jason;Toxicol Appl Pharmacol,2004

3. Antisense technologies: improvement through novel chemical modifications;Kurreck;Eur J Biochem,2003

4. A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides;Levin;Biochim Biophys Acta,1999

5. Characterization of antisense oligonucleotides comprising 2′-deoxy-2′-fluoro-beta-d-arabinonucleic acid (FANA): specificity, potency, and duration of activity;Ferrari;Ann NY Acad Sci,2006

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antisense targeting of FOXP3+ Tregs to boost anti-tumor immunity;Frontiers in Immunology;2024-08-21

2. Tissue pharmacokinetics of antisense oligonucleotides;Molecular Therapy - Nucleic Acids;2024-03

3. Inhalable Bottlebrush Polymer Bioconjugates as Vectors for Efficient Pulmonary Delivery of Oligonucleotides;ACS Nano;2023-12-26

4. Inhibition of SARS-CoV-2 infection in human airway epithelium with a xeno-nucleic acid aptamer;Respiratory Research;2023-11-07

5. The safety and toxicity profile of SPL84, an inhaled antisense oligonucleotide for treatment of cystic fibrosis patients with the 3849 +10kb C->T mutation, supports a Phase 1/2 clinical study;Expert Opinion on Drug Metabolism & Toxicology;2023-10-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3